Cargando…

Refining eligibility criteria of unit selection for myeloablative cord blood transplantation in acute leukemia: Real‐world experience of a referral center

The algorithm for cord blood (CB) unit selection is still somewhat ambiguous. We retrospectively analyzed 620 cases of acute leukemia between 2015 and 2020, who were treated with myeloablative single‐unit umbilical CB transplantation (UCBT). We found that, when human leukocyte antigen (HLA) mismatch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zimin, Hu, Yu, Ji, Yanping, Liu, Xueou, Gong, Xiaowen, Feng, Yahui, Liu, Huilan, Zhang, Wei, Qi, Saibing, Shen, Qiujin, Song, Kaidi, Geng, Liangquan, Yao, Wen, Wan, Xiang, Tang, Baolin, Zhu, Xiaoyu, Sun, Guangyu, Qiang, Ping, Song, Zhen, Chen, Junren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188464/ https://www.ncbi.nlm.nih.gov/pubmed/37206286 http://dx.doi.org/10.1002/jha2.703

Ejemplares similares

Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?
por: Chen, Junren, et al.
Publicado: (2023)

Correction: Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?
por: Chen, Junren, et al.
Publicado: (2023)

Treating Relapsed/Refractory Acute Myeloid Leukemia with Chidamide, Fludarabine, Cytarabine and Granulocyte-Colony Stimulating Factor with Subsequent Bridging to Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
por: Yao, Wen, et al.
Publicado: (2022)

The Composite Immune Risk Score predicts overall survival after allogeneic hematopoietic stem cell transplantation: A retrospective analysis of 1838 cases
por: Cao, Yigeng, et al.
Publicado: (2023)

‘Dynamic zero-COVID’ policy and viral clearance during an omicron wave in Tianjin, China: a city-wide retrospective observational study
por: Feng, Yahui, et al.
Publicado: (2022)

Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study
por: Sun, Zimin, et al.
Publicado: (2018)

Have we been qualifying measurable residual disease correctly?
por: Feng, Yahui, et al.
Publicado: (2023)

Cytomegalovirus-Specific T Cells from Third-Party Donors Successfully Treated Refractory Cytomegalovirus Retinitis after Unrelated Umbilical Cord Blood Transplantation
por: Li, Na, et al.
Publicado: (2022)

Withdrawal: Down‐regulation of circRNA_0000143 regulates miR‐142‐3p/GRα axis to facilitate the progression of T‐ALL
por: Tong, Juan, et al.
Publicado: (2023)

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2019)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
por: Zhou, Li, et al.
Publicado: (2019)

Transplants of unrelated cord blood or sibling allogeneic peripheral blood stem cells/bone marrow in adolescent and young adults with chronic myeloid leukemia: comparable outcomes but better chronic GVHD-free and relapse-free survival among survivors with cord blood
por: Zheng, Changcheng, et al.
Publicado: (2017)

The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study
por: Ge, Jing, et al.
Publicado: (2018)

Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival
por: Tong, Juan, et al.
Publicado: (2021)

Unrelated cord blood transplantation vs. HLA-matched sibling transplantation for adults with B-cell acute lymphoblastic leukemia in complete remission: superior OS for patients with long-term survival
por: Sun, Guangyu, et al.
Publicado: (2022)

A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients
por: Zhou, Li, et al.
Publicado: (2016)

Donor KIR3DL1/receptor HLA-Bw4-80I Combination Reduces Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-cell Depletion
por: Fang, Xinchen, et al.
Publicado: (2021)

Dynamic comparison of early immune reactions and immune cell reconstitution after umbilical cord blood transplantation and peripheral blood stem cell transplantation
por: Zhao, Xuxu, et al.
Publicado: (2023)

Extraordinarily elevated CD33 expression in CD56(+)CD3(–) cells in the bone marrow of a patient with relapsed acute myeloid leukemia: a case report
por: Wang, Dongyao, et al.
Publicado: (2021)

The criteria of eligibility to the extracorporeal treatment
por: Zangrillo, A
Publicado: (2012)

The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
por: Zhu, Shengyun, et al.
Publicado: (2021)

A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms
por: Shen, Qiujin, et al.
Publicado: (2022)

Inflammatory monocytes promote pre-engraftment syndrome and tocilizumab can therapeutically limit pathology in patients
por: Jin, Linlin, et al.
Publicado: (2021)

Epilepsy surgery: eligibility criteria and presurgical evaluation
por: Ryvlin, Philippe, et al.
Publicado: (2008)

Analysis of Eligibility Criteria Complexity in Clinical Trials
por: Ross, Jessica, et al.
Publicado: (2010)

Correction: The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
Publicado: (2022)

Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells
por: Xu, Qianwen, et al.
Publicado: (2022)

Chia, a large annotated corpus of clinical trial eligibility criteria
por: Kury, Fabrício, et al.
Publicado: (2020)

A review of research on eligibility criteria for clinical trials
por: Su, Qianmin, et al.
Publicado: (2023)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017)

The impact of eligibility criteria on enrollment in ICU sepsis clinical trials
por: Foster, D, et al.
Publicado: (1999)

Long-Term Care Eligibility Criteria for People with Alzheimer's Disease
por: Fox, Patrick, et al.
Publicado: (1999)

Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria
por: Franzen, Sanne, et al.
Publicado: (2021)

Anatomic Repair of Congenitally Corrected Transposition: Reappraisal of Eligibility Criteria
por: Weixler, Viktoria H. M., et al.
Publicado: (2022)

Splenocytes Seed Bone Marrow of Myeloablated Mice: Implication for Atherosclerosis
por: Wang, Lai, et al.
Publicado: (2015)

Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
por: Sun, Xuqi, et al.
Publicado: (2021)

Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting
por: Tong, Juan, et al.
Publicado: (2021)

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
por: Nakamura, R, et al.
Publicado: (2002)

Discordance between clinical and immunological ART eligibility criteria for children in Malawi
por: O’Hare, Bernadette, et al.
Publicado: (2014)

An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria
por: Si, Yuqi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pkb736q95u1bjob5vd05tvv8ns